# Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)

> **NCT01389817** · PHASE1,PHASE2 · TERMINATED · sponsor: **Medical College of Wisconsin** · enrollment: 4 (actual)

## Conditions studied

- Leber's Hereditary Optic Neuropathy (LHON)

## Interventions

- **DEVICE:** Near-infrared light-emitting diode (NIR-LED) therapy (Med Light 630 PRO (Medical Devices Inc.))

## Key facts

- **NCT ID:** NCT01389817
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Unable to record n95 pERG peak (primary measure), as LHON subjects are unable to focus on target.
- **Last updated:** 2014-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01389817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01389817, "Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01389817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*